Helicon is a pro-active company that actively searches for Special Situation Opportunities and has committed to limit itself to a handful of the best of these in order to provide optimal focus and resources to ensure success for its partners and stakeholders. Helicon utilises a low cost operating overhead base in combination with established channel partners for clinical development, product registration, business development, marketing, promotion and sales.

The Company’s strategy is to secure products that have been developed by other pharmaceutical and biomedical companies and that have successfully completed independent clinical trials and have been approved for market release by regulators such as the US Food and Drug Administration (FDA) and/or Conformite Europeene (CE). Helicon then manages the regulatory approvals programme in China and other North Asian markets through contracted expert regulatory advisers. Important selection criteria include the potential for a premium market, secure intellectual property and know how, technology and manufacturing processes that are difficult to reverse engineer, and a target rate of return on investment.

Helicon is an unique company listed on Australian Securities Exchange (ASX) as it is one of the very few medical companies that seek to explore the fast growing healthcare opportunities in China.

Helicon is listed on ASX under its code: HCG, for more information about Helicon, please visit its website www.helicongroup.com.au

Disclaimer: Helicon is a paid client to Money Cat Group, the owner of www.smallcapwrap.com

Green Investors Profile: Utilities Companies

Many utilities companies are also important strategic investors for cleantech, smartgrid, energy efficiency and energy management technologies; as well as renewable energy companies, for example, some utilities companies have taken strategic shareholding in geothermal energy companies, clean coal providers, also solar farms, wind farms and biofuel.

In this post, we would like to share some companies profile with other members, and hope you find them useful.

RWE AG

RWE AG is engaged in the business of generation, trading, transmission and supply of electricity and gas. The Company operates through seven divisions. Germany, Netherlands/Belgium, United Kingdom, Central and Eastern Europe, Renewables, Upstream gas and oil, and Trading/gas midstream. The Company acquired the Dutch energy utility Essent N.V. as of September 30, 2009.

The Company’s Germany division consists of the Generation and Sales and distribution networks business areas. It also includes the German regional utilities, which operate their own electricity generation facilities to a small extent, besides handling the network and end-customer business. The United Kingdom business division encompasses its entire United Kingdom generation and supply business with the exception of electricity production from renewable; it is an active investor especially in solar and wind energy projects.

China Yangtze Power Co, Ltd (CHINA)

China Yangtze Power Co., Ltd. is principally engaged in electric power generation and supply. The Company operates hydropower plants. It operates its businesses through electric power generation, operation and investment; electric generation technology consulting, as well as monitoring and maintenance of hydropower engineering.

During the year ended December 31, 2009, the Company generated approximately 51.37 billion kilowatt hours of electric power. The Company had six subsidiaries and six affiliates, which involved in technology, industrial and security investment, property management, equipment leasing, engineering consulting, financial services, electric and heat power generation, as well as nonferrous metal smelting.

Like other Chinese utilities companies, they are active in investing in green technologies but also seeking resources globally such as coal.

Covanta Holdings (USA)

Covanta Holding Corporation (Covanta) is a developer, owner and operator of infrastructure for the conversion of waste to energy (known as energy-from-waste), as well as other waste disposal and renewable energy production businesses in the Americas, Europe and Asia. The Company conducts all of its operations through subsidiaries, which are engaged predominantly in the businesses of waste and energy services. Covanta is also engaged in the independent power production business outside the Americas. It has investments in subsidiaries engaged in insurance operations in California, primarily in property and casualty insurance.

The Company operates in two segments: Americas and International. The Americas segment is comprised of waste and energy services operations primarily in the United States and Canada. The International segment is comprised of waste and energy services operations in other countries, the United Kingdom, Ireland, Italy, China, The Philippines, India, and Bangladesh.

This is an interesting company, as we have also researched into other waste-energy conversion companies; many have taken either minority or strategic investments into new cleantech technologies as a strategy to stay competitive and diversify into new products.

Looking for investment sources and ideas? Check out our Global Green Investors Guide and Global Utilities Companies Guide on http://researchwhitepaper.com

Some Green Investors Profile to Share

There were continuing positive developments in green investments ; first, the total investment into the sector continues to show strong momentum across the world; and the there are also more companies announcing new investment funds into cleantech & renewable energy opportunities. Here are some more companies for you to consider:

TechFund Capital Europe

This is an interesting company, which invests in information and clean energy technology sectors where our hands-on experience can help create disruption leaders. In information technologies we focus on networking & communications and digital media.

In clean energy technologies, it concentrate on distributed generation, energy efficiency, eco-intelligence and renewable energy technologies as areas where new approaches are needed and where a multi-discipline expertise is essential. To give you some examples, the types of opportunities are smart grid technologies, systems that can manage power and water flow more accurately; and also systems that can detect faults in the grids; and software that improve energy efficiency.

Southern Cross Venture Partners

Southern Cross Venture Partners was launched in 2006 by veteran venture capitalists who have managed and operated companies themselves. It assists early stage technology companies that demonstrate the potential for exceptional growth and market leadership build significant businesses. Typical initial investment will be $2 million to $5 million with an ability to invest more money in later rounds. Southern Cross Venture Partners is based in Australia; and have started to invest in some opportunities relating to cleantech and renewable energy sectors. Xerocoat, for instance, is a solar materials company based in California, and has received investments from Southern Cross recently.

Advantage Capital Partners

Advantage Capital Partners is a venture capital firm specializing in growth equity and mezzanine debt capital investment in companies at all stages except seed. It seeks to invest in companies that develop or apply technologies or approaches to products, systems, and services primarily in the communication, information technology, life sciences, and energy industry, but also considers other opportunities. Cleantech investing is its fastest growing segment, its portfolio include Grid Point, a smart grid technology company, SOMS Technology, an oil filter technology, Soy Energy and other cleantech & renewable energy, sustainable agribusinesses.

The above companies are extracts from our Global Green Investors Guide, which is now available from http://researchwhitepaper.com, this database contains hundreds of investment firms that invest in cleantech or renewable energy opportunities.

Weekly Global Solar Companies Profile

We continue to search for information on major and upcoming solar companies around the world. Our search has revealed a lot of companies and technologies both from established and emerging solar markets, some of these companies will definitely become the world’s future solar leaders.

We would like to share company profile with other members on these forums; we will cover both directly related and indirectly related solar companies around the world.

Deutsche Solar AG (Germany)

Deutsche Solar AG produces mono and multi-crystalline silicon wafers for photovoltaic industry.

It also provides recycling services, such as purification, recycling, and classification of silicon material; surface treatment of wafers, cells, and silicon materials; recycling of photovoltaic modules; manufacture of special silicon blocks; and research services.

Deutsche Solar AG was formerly known as Deutsche Solar GmbH and changed its name to Deutsche Solar AG in February 2002. The company was founded in 1994 and is based in Freiberg, Germany. Deutsche Solar AG operates as a subsidiary of SolarWorld AG.

Deutsche Solar AG is one of the many successful solar companies based in Germany, I can’t recall the latest figure, but I remember Germany is now ranks 3^rd or 4^th in terms of solar industry in the world.

Relevance: Solar technology, manufacturer

Entegra Limited (India)

Although not a solar technology or manufacturer, Entegra is a leading renewable energy company, and it has participated in different types of solar infrastructure projects around India.

Entegra Limited is an India-based Company. The Company is an integrated global renewable energy company. The Company is organized in three segments: Energy Services; Infrastructure Projects, which is engaged in divestment in power project.

The Maheshwar Hydro Electric Project (MHEP) has a generation capacity of 400 megawatts (10*40 megawatts) with an energy generation potential of l, 500 million units per annum.  EnnerGreen Solutions comprises projects, products and services divisions, which also include adopting or developing solar energy.

Relevance: Power generation, utilities company, potential solar farm financing partner

First Solar

First Solar, Inc. designs and manufactures solar modules using a thin film semiconductor technology. The Company’s solar modules employ a thin layer of cadmium telluride semiconductor material to convert sunlight into electricity.

Each solar module is approximately 2 feet by 4 feet (60 centimeters by 120 centimeters) and had an average rated power of approximately 73 watts。

Its solar module is a single-junction polycrystalline thin film structure that uses cadmium telluride as the absorption layer and cadmium sulfide as the window layer.

The Company’s solar power systems and project development business provides a variety of integrated services to its customers as part of a system solution delivery. These services include solar power system design, procurement of permits and balance of system components, construction management, monitoring and maintenance.

Relevance: Solar Technology & Manufacturer, Solar Components

In future weeks, we will look into companies including solar technology, manufacturers, solar components and solar investors. If you are looking for information on solar industry, please check out our Global Solar Companies Guide now available on http://researchwhitepaper.com

This month, we have introduced a new initiative to provide more information about investment activities in the Global Cleantech & Renewable sectors, there has been more and more activities; both in United States and also in global markets. We have introduced a new News summary relating to Green investments, we will select a number of key announcements as part of our Global Green Investors Guide each month.

The number of contacts in our Global Green Investors Guide now stands at 4,200, comprising approximately 1,000 Green industry related investment companies; this include venture capital firms, private equity firms, corporate advisory firms; and also Government sponsored programs and initiatives. The latter (Government Incentives and Programs) is an area which we intend to expand over next few months.

Investment Firms and Companies included in our Global Green Investors Guide range are diversified, including companies from North America, Europe and Asia Pacific regions. This report is now available both in Excel and Word (or PDF); including monthly updates for 12 months.

Where to Find Green Investors?

There are many sources you can consider:

1)      Venture Capital Funds which are looking to invest in either start-up or expansion opportunities

2)      Private Equity Funds which invest in larger deals, such as infrastructure, or MBO or M&A deals

3)      University Innovation Programs / VCs – There are increasing number of University sponsored or affiliated networks that provide funding and commercialization supports for Green innovations

4)      Government (State and Federal) Grants and Programs – There are different programs available from different States that are available for innovators

5)      Energy companies – well, the big oil & gas companies are actually major investors in renewable energy; such as Shell, Chevron.

6)      Utilities companies – likewise, utilities companies have also formed their own investment arms, especially relating to smart grid, energy efficiency and energy distribution technologies; as well as project funding.

If you are interested to know more about our Global Green Investors Guide, please visit our website http://researchwhitepaper.com for more information.

Active Biotechnology & Medical Venture Capital Investors

Interests in biotechnology & medical industries continue to attract interests from investors, turmoils in Euro zone however, may have caused some uncertainties in terms of European venture capital investors investing into  North American opportunities due to volatility in exchange rates.

Nevertheless, investments have not stopped flowing into this sector, here are some more investors for you to consider in the world of biotechnology/medical investments:

Baird Venture Partners (US)

Baird Venture Partners is an emerging biotechnology / life-science venture capital firm. The company currently has US$200m plus venture capital fund focus on biotechnology and life science sectors.

Baird Venture Partners, the U.S.-based venture capital fund of Baird Private Equity, makes investments in early- and expansion-stage companies in the Business Services and Healthcare/Life Sciences sectors.

In the Healthcare / Life Sciences sectors, they are especially focused on Medical Devices / Equipment sectors, including information management (healthcare IT (HIT)) opportunities; as well as healthcare services companies. Baird Venture Partners is based in Chicago, and invests in national opportunities.

BioFusion Capital (Australia)

BioFusion Capital was formed in March 2002 and was granted registration as a Pooled Development Fund in May 2002. You may not think of Australia when comes to healthcare / medical investments, in fact, Australia has enjoyed some successes with a number of global players; notably CSL, Cochlear, ResMed and iSoft (IBA Health). Australian venture capital firms have enjoyed some exceptional successes especially in the areas of medical devices.

Abingworth (UK)

London based Abingworth is a long-established venture capital firm dedicated to the life sciences sector on both sides of the Atlantic. The company invests across all stages of development, including early-stage as well as public companies. Its focus are in building up early and late stage medical companies, typically investing in the range of $20 to $80 million, Abinworth is an international investor, although its primary focus are US, UK and Europe. The company will also invest in public listed early stage healthcare companies.

We hope you find these profile of healthcare / medical investors of use and interest. For more information about Global investors in the healthcare, medical and pharmaceutical sectors, please check out our Global Biotechnology Capital Providers Guide on http://researchwhitepaper.com

Global Biotechnology Capital Providers Guide Updates & Some Findings

We have completed our first update of our Global Biotechnology Capital Providers Guide which include over 900 investment firms and 4,000+ contacts on companies that invest in biotechnology, life-science, medical devices as well as e-health/health informatics industries.

We will be adding more investment firms especially updating those from emerging markets and Asia Pacific regions in June, customers of our Global Biotechnology Capital Providers Guide will also receive complimentary updates as well.

We have updated contacts of these investment firms, and in our next update, we will also provide further segmentation to the guide, identifying what sectors they specialize in.

In short, 2010 is an interesting year for biotechnology sectors, although the sector may not attract as much attention as in the case for cleantech/renewable energy sectors; there have been much more activities compared to 2009.

Certain sectors have especially attracted more attention from investors, especially medical devices and E-health sectors where there are less R&D risks involved, and the demand for medical devices has been increasing steadily and is now one of the most important exporting industry for Western companies to China, which is another reason behind the growth. Medical devices is a very broad term which can include preventative and treatment devices; as well as specific devices for ageing population including hearing aids, sleeping assistance devices, optical equipment and diagnostic devices analysing medical results.

E-health on another hand has been highlighted by us as a key sector to attract investments. They are often classified as technology investments rather than life-science related investments. The increasing adoption of E-health systems, as well as global standardization for medical reports, file transfers; supported by advancements in telecommunications infrastructure have been key catalysts behind the success of many E-health companies; and subsequently for venture capital investors.

If you are looking for investors for your current or upcoming biotechnology / life-sciences opportunities, please visit our website http://researchwhitepaper.com for more details about our Global Biotechnology Capital Providers Guide.